Hydroxocobalamine Focus Care

Hydroxocobalamin, the active ingredient in Hydroxocobalamine Focus Care, is a vitamin B12 (cobalamin) presented as a sterile injectable for intramuscular use. It is prescribed for the treatment of vitamin B12 deficiency, cobalamin deficiency anemia, and cyanide poisoning.

GNH USA supplies Hydroxocobalamine Focus Care as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Hydroxocobalamin acts as a vitamin B12 replacement in conditions where cobalamin is deficient or required for detoxification. - Vitamin B12 deficiency: restores normal B12 levels and supports red blood cell formation. - Cobalamin deficiency anemia: corrects megaloblastic anemia by enabling DNA synthesis in hematopoietic cells. - Cyanide poisoning: binds cyanide ions to form cyanocobalamin, facilitating rapid detoxification.

Adverse reactions may occur following intramuscular administration of hydroxocobalamin.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Headache: transient headache occurring within hours. - Nausea: occasional mild nausea. - Flushing: temporary skin reddening.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe hypotension: marked drop in blood pressure post‑injection. - Stevens‑Johnson syndrome: rare severe skin reaction. - Hemolytic anemia: uncommon destruction of red blood cells. - Severe allergic reaction: includes angioedema or bronchospasm.

Before prescribing hydroxocobalamin, clinicians should consider several safety measures. - Allergy assessment: verify no known hypersensitivity to cobalamin or formulation excipients. - Renal impairment: monitor renal function, as the drug is primarily renally excreted. - Pregnancy: use only if potential benefits justify potential risks, given limited data. - Concurrent cyanide exposure: evaluate need for adjusted dosing in acute poisoning scenarios. - Storage at room temperature (below 25°C): keep in the original container, protect from moisture and light.

Hydroxocobalamin may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Nitrous oxide anesthesia: can precipitate severe B12 deficiency; avoid concurrent use. - Chloramphenicol: may interfere with hematopoiesis, increasing anemia risk. - High‑dose vitamin C: may reduce hydroxocobalamin’s ability to bind cyanide.

Moderate Interactions (Monitor Closely): - Metformin: may lower systemic B12 levels; monitor patient status. - Proton pump inhibitors: can affect overall B12 status; consider periodic assessment. - Oral folic acid: may mask hematologic signs of B12 deficiency; monitor clinical response.